Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 181

2.

Phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor growth and prognosis in patients with bladder cancer: correlation with matrix metalloproteinase-2 and -7 and E-cadherin.

Miyata Y, Sagara Y, Kanda S, Hayashi T, Kanetake H.

Hum Pathol. 2009 Apr;40(4):496-504. doi: 10.1016/j.humpath.2008.09.011. Epub 2009 Jan 3.

PMID:
19121849
3.

TFE3-renal carcinoma in an adult patient: a case with strong expression of phosphorylated hepatocyte growth factor (HGFR)/Met.

Sagara Y, Miyata Y, Nomata K, Abe K, Eguchi J, Hayashi T, Sakai H, Kanda S, Kanetake H.

Pathol Res Pract. 2009;205(1):57-61. doi: 10.1016/j.prp.2008.08.001. Epub 2008 Oct 17.

PMID:
18930356
4.

[Expression of HGF and its receptor c-Met in renal cell carcinoma].

Shi BB, Zhang XH, Wang HJ, Li HZ.

Zhonghua Zhong Liu Za Zhi. 2004 Jun;26(6):356-8. Chinese.

PMID:
15312347
5.

Clinical relevance of hepsin and hepatocyte growth factor activator inhibitor type 2 expression in renal cell carcinoma.

Betsunoh H, Mukai S, Akiyama Y, Fukushima T, Minamiguchi N, Hasui Y, Osada Y, Kataoka H.

Cancer Sci. 2007 Apr;98(4):491-8. Epub 2007 Feb 16.

6.
7.

Hepatocyte growth factor receptor in human RPE cells: implications in proliferative vitreoretinopathy.

Lashkari K, Rahimi N, Kazlauskas A.

Invest Ophthalmol Vis Sci. 1999 Jan;40(1):149-56.

PMID:
9888438
9.

Overexpression of c-met proto-oncogene associated with chromophilic renal cell carcinoma with papillary growth.

Inoue K, Karashima T, Chikazawa M, Iiyama T, Yoshikawa C, Furihata M, Ohtsuki Y, Shuin T.

Virchows Arch. 1998 Dec;433(6):511-5.

PMID:
9870683
10.

C-met proto-oncogene expression in benign and malignant human renal tissues.

Pisters LL, el-Naggar AK, Luo W, Malpica A, Lin SH.

J Urol. 1997 Sep;158(3 Pt 1):724-8.

PMID:
9258068
11.

Differential expression of Axl and Gas6 in renal cell carcinoma reflecting tumor advancement and survival.

Gustafsson A, Martuszewska D, Johansson M, Ekman C, Hafizi S, Ljungberg B, Dahlb├Ąck B.

Clin Cancer Res. 2009 Jul 15;15(14):4742-9. doi: 10.1158/1078-0432.CCR-08-2514. Epub 2009 Jun 30.

12.

Prognostic significance of tenascin-C expression in clear cell renal cell carcinoma.

Ohno Y, Izumi M, Yoshioka K, Ohori M, Yonou H, Tachibana M.

Oncol Rep. 2008 Sep;20(3):511-6.

PMID:
18695899
13.

Immunodetection of c-met-oncogene's protein product in renal cell neoplasia.

Nakopoulou L, Vouriakou C, Papaliodi E, Lazaris AC, Stefanaski K, Michalopoulos G.

Pathol Res Pract. 1997;193(4):299-304.

PMID:
9258956
14.

Effect of hepatocyte growth factor on cell cycle and c-met expression in human gastric cancer cells.

Liu SI, Lui WY, Mok KT, Wu CW, Chi CW.

Anticancer Res. 1997 Sep-Oct;17(5A):3575-80.

PMID:
9413205
15.

Tyrosine phosphorylation of p145met mediated by EGFR and Src is required for serum-independent survival of human bladder carcinoma cells.

Yamamoto N, Mammadova G, Song RX, Fukami Y, Sato K.

J Cell Sci. 2006 Nov 15;119(Pt 22):4623-33. Epub 2006 Oct 24.

16.

Coexpression of hepatocyte growth factor and receptor (Met) in human breast carcinoma.

Tuck AB, Park M, Sterns EE, Boag A, Elliott BE.

Am J Pathol. 1996 Jan;148(1):225-32.

17.

Lymphangiogenesis and angiogenesis in conventional renal cell carcinoma: association with vascular endothelial growth factors A to D immunohistochemistry.

Iwata T, Miyata Y, Kanda S, Nishikido M, Hayashi T, Sakai H, Kanetake H.

Urology. 2008 Apr;71(4):749-54. doi: 10.1016/j.urology.2007.10.063. Epub 2008 Mar 4.

PMID:
18295862
18.

Pathologic significance and prognostic value of phosphorylated cortactin expression in patients with sarcomatoid renal cell carcinoma.

Matsuo T, Miyata Y, Watanabe S, Ohba K, Hayashi T, Kanda S, Sakai H.

Urology. 2011 Aug;78(2):476.e9-15. doi: 10.1016/j.urology.2011.03.019. Epub 2011 Jun 21.

PMID:
21696810
19.

The hypoxic environment in tumor-stromal cells accelerates pancreatic cancer progression via the activation of paracrine hepatocyte growth factor/c-Met signaling.

Ide T, Kitajima Y, Miyoshi A, Ohtsuka T, Mitsuno M, Ohtaka K, Miyazaki K.

Ann Surg Oncol. 2007 Sep;14(9):2600-7. Epub 2007 May 30.

PMID:
17534684
20.

Supplemental Content

Support Center